Global Inhaled Nitric Oxide Market Growth 2024-2030

Publication ID:

LPI01240657

Publication Date:

January 4, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Inhaled Nitric Oxide market size was valued at US$ 1060.4 million in 2023. With growing demand in downstream market, the Inhaled Nitric Oxide is forecast to a readjusted size of US$ 1890.5 million by 2030 with a CAGR of 8.6% during review period.
The research report highlights the growth potential of the global Inhaled Nitric Oxide market. Inhaled Nitric Oxide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Inhaled Nitric Oxide. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Inhaled Nitric Oxide market.
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.
North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.
In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.
Key Features:
The report on Inhaled Nitric Oxide market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Inhaled Nitric Oxide market. It may include historical data, market segmentation by Type (e.g., 800 ppm, 100 ppm), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Inhaled Nitric Oxide market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Inhaled Nitric Oxide market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Inhaled Nitric Oxide industry. This include advancements in Inhaled Nitric Oxide technology, Inhaled Nitric Oxide new entrants, Inhaled Nitric Oxide new investment, and other innovations that are shaping the future of Inhaled Nitric Oxide.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Inhaled Nitric Oxide market. It includes factors influencing customer ' purchasing decisions, preferences for Inhaled Nitric Oxide product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Inhaled Nitric Oxide market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Inhaled Nitric Oxide market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Inhaled Nitric Oxide market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Inhaled Nitric Oxide industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Inhaled Nitric Oxide market.
Market Segmentation:
Inhaled Nitric Oxide market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
800 ppm
100 ppm
Others
Segmentation by application
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Other Diseases
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)
Key Questions Addressed in this Report
What is the 10-year outlook for the global Inhaled Nitric Oxide market?
What factors are driving Inhaled Nitric Oxide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inhaled Nitric Oxide market opportunities vary by end market size?
How does Inhaled Nitric Oxide break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Inhaled Nitric Oxide Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Inhaled Nitric Oxide by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Inhaled Nitric Oxide by Country/Region, 2019, 2023 & 2030
2.2 Inhaled Nitric Oxide Segment by Type
2.2.1 800 ppm
2.2.2 100 ppm
2.2.3 Others
2.3 Inhaled Nitric Oxide Sales by Type
2.3.1 Global Inhaled Nitric Oxide Sales Market Share by Type (2019-2024)
2.3.2 Global Inhaled Nitric Oxide Revenue and Market Share by Type (2019-2024)
2.3.3 Global Inhaled Nitric Oxide Sale Price by Type (2019-2024)
2.4 Inhaled Nitric Oxide Segment by Application
2.4.1 Near-term and Pre-term Infants PPHN
2.4.2 Children and Adult ARDS
2.4.3 Other Diseases
2.5 Inhaled Nitric Oxide Sales by Application
2.5.1 Global Inhaled Nitric Oxide Sale Market Share by Application (2019-2024)
2.5.2 Global Inhaled Nitric Oxide Revenue and Market Share by Application (2019-2024)
2.5.3 Global Inhaled Nitric Oxide Sale Price by Application (2019-2024)
3 Global Inhaled Nitric Oxide by Company
3.1 Global Inhaled Nitric Oxide Breakdown Data by Company
3.1.1 Global Inhaled Nitric Oxide Annual Sales by Company (2019-2024)
3.1.2 Global Inhaled Nitric Oxide Sales Market Share by Company (2019-2024)
3.2 Global Inhaled Nitric Oxide Annual Revenue by Company (2019-2024)
3.2.1 Global Inhaled Nitric Oxide Revenue by Company (2019-2024)
3.2.2 Global Inhaled Nitric Oxide Revenue Market Share by Company (2019-2024)
3.3 Global Inhaled Nitric Oxide Sale Price by Company
3.4 Key Manufacturers Inhaled Nitric Oxide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhaled Nitric Oxide Product Location Distribution
3.4.2 Players Inhaled Nitric Oxide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Inhaled Nitric Oxide by Geographic Region
4.1 World Historic Inhaled Nitric Oxide Market Size by Geographic Region (2019-2024)
4.1.1 Global Inhaled Nitric Oxide Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Inhaled Nitric Oxide Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Inhaled Nitric Oxide Market Size by Country/Region (2019-2024)
4.2.1 Global Inhaled Nitric Oxide Annual Sales by Country/Region (2019-2024)
4.2.2 Global Inhaled Nitric Oxide Annual Revenue by Country/Region (2019-2024)
4.3 Americas Inhaled Nitric Oxide Sales Growth
4.4 APAC Inhaled Nitric Oxide Sales Growth
4.5 Europe Inhaled Nitric Oxide Sales Growth
4.6 Middle East & Africa Inhaled Nitric Oxide Sales Growth
5 Americas
5.1 Americas Inhaled Nitric Oxide Sales by Country
5.1.1 Americas Inhaled Nitric Oxide Sales by Country (2019-2024)
5.1.2 Americas Inhaled Nitric Oxide Revenue by Country (2019-2024)
5.2 Americas Inhaled Nitric Oxide Sales by Type
5.3 Americas Inhaled Nitric Oxide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhaled Nitric Oxide Sales by Region
6.1.1 APAC Inhaled Nitric Oxide Sales by Region (2019-2024)
6.1.2 APAC Inhaled Nitric Oxide Revenue by Region (2019-2024)
6.2 APAC Inhaled Nitric Oxide Sales by Type
6.3 APAC Inhaled Nitric Oxide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Inhaled Nitric Oxide by Country
7.1.1 Europe Inhaled Nitric Oxide Sales by Country (2019-2024)
7.1.2 Europe Inhaled Nitric Oxide Revenue by Country (2019-2024)
7.2 Europe Inhaled Nitric Oxide Sales by Type
7.3 Europe Inhaled Nitric Oxide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Inhaled Nitric Oxide by Country
8.1.1 Middle East & Africa Inhaled Nitric Oxide Sales by Country (2019-2024)
8.1.2 Middle East & Africa Inhaled Nitric Oxide Revenue by Country (2019-2024)
8.2 Middle East & Africa Inhaled Nitric Oxide Sales by Type
8.3 Middle East & Africa Inhaled Nitric Oxide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhaled Nitric Oxide
10.3 Manufacturing Process Analysis of Inhaled Nitric Oxide
10.4 Industry Chain Structure of Inhaled Nitric Oxide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhaled Nitric Oxide Distributors
11.3 Inhaled Nitric Oxide Customer
12 World Forecast Review for Inhaled Nitric Oxide by Geographic Region
12.1 Global Inhaled Nitric Oxide Market Size Forecast by Region
12.1.1 Global Inhaled Nitric Oxide Forecast by Region (2025-2030)
12.1.2 Global Inhaled Nitric Oxide Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Inhaled Nitric Oxide Forecast by Type
12.7 Global Inhaled Nitric Oxide Forecast by Application
13 Key Players Analysis
13.1 Mallinckrodt
13.1.1 Mallinckrodt Company Information
13.1.2 Mallinckrodt Inhaled Nitric Oxide Product Portfolios and Specifications
13.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Mallinckrodt Main Business Overview
13.1.5 Mallinckrodt Latest Developments
13.2 Praxair (Linde plc)
13.2.1 Praxair (Linde plc) Company Information
13.2.2 Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolios and Specifications
13.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Praxair (Linde plc) Main Business Overview
13.2.5 Praxair (Linde plc) Latest Developments
13.3 Air Liquide
13.3.1 Air Liquide Company Information
13.3.2 Air Liquide Inhaled Nitric Oxide Product Portfolios and Specifications
13.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Air Liquide Main Business Overview
13.3.5 Air Liquide Latest Developments
13.4 BOC Healthcare (Linde Group)
13.4.1 BOC Healthcare (Linde Group) Company Information
13.4.2 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolios and Specifications
13.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BOC Healthcare (Linde Group) Main Business Overview
13.4.5 BOC Healthcare (Linde Group) Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂